Perlman, Amichai
Goldstein, Rachel
Choshen Cohen, Lotan
Hirsh-Raccah, Bruria
Hakimian, David
Matok, Ilan
Kalish, Yosef
Singer, Daniel E.
Muszkat, Mordechai http://orcid.org/0000-0002-9520-1379
Article History
Accepted: 16 January 2021
First Online: 17 February 2021
Change Date: 3 August 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s40263-021-00844-7
Declarations
:
: None.
: A Perlman is an employee at K-health Inc; the work presented in this manuscript is not related to his work at K-health. DE Singer is an employee of Massachusetts General Hospital. Dr. Singer has received research funding from Bristol Myers Squibb and has served as a paid consultant and/or member of advisory boards for Boehringer Ingelheim, Bristol Myers Squibb, Fitbit, Johnson and Johnson, Merck, and Pfizer. M Muszkat has received honoraria from Roche and a research grant from Pfizer Independent Global Medical Grant. R Goldstein, L Cohen, B Hirsh-Raccah, D Hakimian, I Matok, and Y Kalish have no conflicts of interest that are directly relevant to the content of this article.
: The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
: The study was approved by the Hadassah Medical Organization Institutional Review Board and was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments.
: This observational study was exempt from obtaining consent from the Hadassah Medical Organization institutional review board.
: All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by AP, RG, BH-R, LCC, DH, IM, YK, DS, and MM. The first draft of the manuscript was written by AP and RG, and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.